Cancer Genetics, Inc.
Country not established
- Devices
- 1
What Cancer Genetics, Inc. makes
Cancer Genetics, Inc. manufactures the Tissue of Origin Test Kit-FFPE, a diagnostic device designed to identify the primary tissue source of metastatic cancer cells in formalin-fixed, paraffin-embedded (FFPE) tissue samples.
The Tissue of Origin Test Kit-FFPE is classified as a Class II medical device under FDA regulations and is authorised via the 510(k) pathway. The company is based in the United States.
Catalogue
Tissue of Origin Test Kit-FFPE Ref K173839
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Cancer Genetics, Inc. have in the registry?
The registry currently lists 1 device for Cancer Genetics, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Cancer Genetics, Inc.'s devices?
Among its 1 most recently registered device, Cancer Genetics, Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Cancer Genetics, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Cancer Genetics, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Cancer Genetics, Inc. in the registry?
The most recently registered devices listed for Cancer Genetics, Inc. include Tissue of Origin Test Kit-FFPE.